Nibbs RJ - Search Results

1

Inhibition of CXCR2 profoundly suppresses inflammation-driven and spontaneous tumorigenesis.

Jamieson T, Clarke M, Steele CW, Samuel MS, Neumann J, Jung A, Huels D, Olson MF, Das S, Nibbs RJ, Sansom OJ. Jamieson T, et al. Among authors: nibbs rj. J Clin Invest. 2012 Sep;122(9):3127-44. doi: 10.1172/JCI61067. Epub 2012 Aug 27. J Clin Invest. 2012. PMID: 22922255 Free PMC article.

2

Granulocyte macrophage colony-stimulating factor and interleukin-3 regulate chemokine and chemokine receptor expression in bone marrow macrophages.

Jarmin DI, Nibbs RJ, Jamieson T, de Bono JS, Graham GJ. Jarmin DI, et al. Among authors: nibbs rj. Exp Hematol. 1999 Dec;27(12):1735-45. doi: 10.1016/s0301-472x(99)00115-0. Exp Hematol. 1999. PMID: 10641591 Free article.

3

The chemokine receptor D6 limits the inflammatory response in vivo.

Jamieson T, Cook DN, Nibbs RJ, Rot A, Nixon C, McLean P, Alcami A, Lira SA, Wiekowski M, Graham GJ. Jamieson T, et al. Among authors: nibbs rj. Nat Immunol. 2005 Apr;6(4):403-11. doi: 10.1038/ni1182. Epub 2005 Mar 6. Nat Immunol. 2005. PMID: 15750596 Free article.

4

The atypical chemokine receptor D6 suppresses the development of chemically induced skin tumors.

Nibbs RJ, Gilchrist DS, King V, Ferra A, Forrow S, Hunter KD, Graham GJ. Nibbs RJ, et al. J Clin Invest. 2007 Jul;117(7):1884-92. doi: 10.1172/JCI30068. J Clin Invest. 2007. PMID: 17607362 Free PMC article.

5

A TLR2 ligand suppresses inflammation by modulation of chemokine receptors and redirection of leukocyte migration.

McKimmie CS, Moore M, Fraser AR, Jamieson T, Xu D, Burt C, Pitman NI, Nibbs RJ, McInnes IB, Liew FY, Graham GJ. McKimmie CS, et al. Among authors: nibbs rj. Blood. 2009 Apr 30;113(18):4224-31. doi: 10.1182/blood-2008-08-174698. Epub 2009 Feb 6. Blood. 2009. PMID: 19202130 Free article.

6

The atypical chemokine receptor D6 contributes to the development of experimental colitis.

Bordon Y, Hansell CA, Sester DP, Clarke M, Mowat AM, Nibbs RJ. Bordon Y, et al. Among authors: nibbs rj. J Immunol. 2009 Apr 15;182(8):5032-40. doi: 10.4049/jimmunol.0802802. J Immunol. 2009. PMID: 19342683 Free PMC article.

7

Cell-autonomous regulation of neutrophil migration by the D6 chemokine decoy receptor.

Rot A, McKimmie C, Burt CL, Pallas KJ, Jamieson T, Pruenster M, Horuk R, Nibbs RJB, Graham GJ. Rot A, et al. J Immunol. 2013 Jun 15;190(12):6450-6456. doi: 10.4049/jimmunol.1201429. Epub 2013 May 13. J Immunol. 2013. PMID: 23670187 Free PMC article.

8

Microarray analyses demonstrate the involvement of type I interferons in psoriasiform pathology development in D6-deficient mice.

Baldwin HM, Pallas K, King V, Jamieson T, McKimmie CS, Nibbs RJ, Carballido JM, Jaritz M, Rot A, Graham GJ. Baldwin HM, et al. Among authors: nibbs rj. J Biol Chem. 2013 Dec 20;288(51):36473-83. doi: 10.1074/jbc.M113.491563. Epub 2013 Nov 5. J Biol Chem. 2013. PMID: 24194523 Free PMC article.

9

Atypical chemokine receptor ACKR2 mediates chemokine scavenging by primary human trophoblasts and can regulate fetal growth, placental structure, and neonatal mortality in mice.

Teoh PJ, Menzies FM, Hansell CA, Clarke M, Waddell C, Burton GJ, Nelson SM, Nibbs RJ. Teoh PJ, et al. Among authors: nibbs rj. J Immunol. 2014 Nov 15;193(10):5218-28. doi: 10.4049/jimmunol.1401096. Epub 2014 Oct 8. J Immunol. 2014. PMID: 25297873

10

CXCR2 inhibition suppresses acute and chronic pancreatic inflammation.

Steele CW, Karim SA, Foth M, Rishi L, Leach JD, Porter RJ, Nixon C, Jeffry Evans TR, Carter CR, Nibbs RJ, Sansom OJ, Morton JP. Steele CW, et al. Among authors: nibbs rj. J Pathol. 2015 Sep;237(1):85-97. doi: 10.1002/path.4555. Epub 2015 Jun 4. J Pathol. 2015. PMID: 25950520 Free PMC article.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

106 results

Search Page